Immutep Ltd. (IMMP)
3.25
-0.01
(-0.31%)
USD |
NASDAQ |
Nov 18, 16:00
3.30
+0.05
(+1.54%)
After-Hours: 05:23
Immutep Price : 3.25 for Nov. 18, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 18, 2026 | 3.16 | 3.500 | 3.06 | 3.25 | 138152.0 |
| Nov 17, 2026 | 3.39 | 3.39 | 3.163 | 3.26 | 6833.00 |
| Nov 16, 2026 | 3.41 | 3.50 | 3.20 | 3.40 | 26680.00 |
| Nov 13, 2026 | 3.65 | 3.76 | 3.422 | 3.48 | 14849.00 |
| Nov 12, 2026 | 3.30 | 3.95 | 3.30 | 3.655 | 61541.00 |
| Nov 11, 2026 | 3.69 | 3.74 | 3.43 | 3.56 | 58707.00 |
| Nov 10, 2026 | 3.63 | 3.69 | 3.40 | 3.46 | 81309.00 |
| Nov 09, 2026 | 3.62 | 3.92 | 3.607 | 3.80 | 65951.00 |
| Nov 06, 2026 | 2.69 | 3.49 | 2.69 | 3.34 | 97169.00 |
| Nov 05, 2026 | 2.95 | 2.995 | 2.66 | 2.69 | 16710.00 |
| Nov 04, 2026 | 3.01 | 3.035 | 2.93 | 2.95 | 5451.00 |
| Nov 03, 2026 | 3.03 | 3.12 | 2.985 | 2.995 | 12173.00 |
| Nov 02, 2026 | 3.10 | 3.111 | 3.00 | 3.07 | 11626.00 |
| Oct 30, 2026 | 3.30 | 3.30 | 3.05 | 3.06 | 10591.00 |
| Oct 29, 2026 | 3.04 | 3.55 | 3.04 | 3.33 | 14038.00 |
| Oct 28, 2026 | 3.19 | 3.46 | 3.19 | 3.32 | 29527.00 |
| Oct 27, 2026 | 3.10 | 3.30 | 3.10 | 3.15 | 13558.00 |
| Oct 26, 2026 | 3.28 | 3.28 | 3.05 | 3.10 | 26999.00 |
| Oct 23, 2026 | 3.21 | 3.23 | 3.10 | 3.20 | 7942.00 |
| Oct 22, 2026 | 3.27 | 3.27 | 3.073 | 3.17 | 7537.00 |
| Oct 21, 2026 | 3.22 | 3.395 | 3.21 | 3.28 | 9210.00 |
| Oct 20, 2026 | 3.15 | 3.420 | 3.15 | 3.26 | 16370.00 |
| Oct 19, 2026 | 3.29 | 3.29 | 3.13 | 3.17 | 6784.00 |
| Oct 16, 2026 | 3.27 | 3.27 | 3.18 | 3.20 | 11869.00 |
| Oct 15, 2026 | 3.31 | 3.31 | 3.06 | 3.21 | 19070.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| CSL Ltd. | 32.90 |
| Ceryvyn Therapeutics Ltd. | 0.028 |
| Propanc Biopharma, Inc. | 1.76 |
| Mesoblast Ltd. | 11.64 |
| Actinogen Medical Ltd. | 0.33 |
Price Related Metrics
| PS Ratio | 2.384 |
| PEG Ratio | -0.0078 |
| Earnings Yield | -224.0% |
| Market Cap | 23.95M |
| PEGY Ratio | -0.0078 |